| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 12/12/2001 | EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors |
| 12/12/2001 | EP1161279A1 Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin |
| 12/12/2001 | EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 12/12/2001 | EP0977584B1 PHARMACEUTICAL PREPARATION COMPRISING vWF PROPEPTIDE |
| 12/12/2001 | EP0699075B1 MODIFIED FACTOR VII for inhibiting vascular restenosis and platelet deposition |
| 12/12/2001 | EP0662088B1 Inhibitor of collagen-stimulated platelet aggregation |
| 12/12/2001 | EP0655921B1 Novel glucan preparation |
| 12/12/2001 | CN1326467A Expression and export of angiostation and endostatin as immunofusins |
| 12/12/2001 | CN1326450A Hydroxyflavone derivatives as tau protein kinase inhibitors |
| 12/12/2001 | CN1326442A Pesticides |
| 12/12/2001 | CN1326361A Methods for detecting, preventing, and treating renal disorders by modulating, regulating and inhibiting connective tissue growth factor |
| 12/12/2001 | CN1326357A Method of treating sickle cell disease and thalassemia |
| 12/12/2001 | CN1326356A Method of treating viral hemorrhagic fever |
| 12/12/2001 | CN1326355A Method of treating heparin-induced thrombocytopenia |
| 12/12/2001 | CN1325699A Oral liquid 'Rongshuanling' |
| 12/11/2001 | US6329526 Cycloalkyl substituted imidazoles |
| 12/11/2001 | US6329421 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 12/11/2001 | US6329372 Phenylalanine derivatives |
| 12/11/2001 | US6329365 Inhibitors of interleukin-1β converting enzyme |
| 12/11/2001 | US6329000 Extract of pine needle and the use thereof |
| 12/11/2001 | US6328966 Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/11/2001 | CA2117953C Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same |
| 12/06/2001 | WO2001092565A2 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 12/06/2001 | WO2001092530A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |
| 12/06/2001 | WO2001092320A2 Use a high-molecular-weight extracellular haemoglobin as blood substitute |
| 12/06/2001 | WO2001092308A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | WO2001092262A1 New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 12/06/2001 | WO2001092253A2 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 12/06/2001 | WO2001092234A1 Pyrazinone thrombin inhibitors |
| 12/06/2001 | WO2001092221A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 12/06/2001 | WO2001092211A1 Compounds exhibiting thrombopoietin-like activities |
| 12/06/2001 | WO2001092202A1 Il-8 receptor antagonists |
| 12/06/2001 | WO2001091803A2 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 12/06/2001 | WO2001091787A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | WO2001091780A1 Neuroprotective peptides |
| 12/06/2001 | WO2001091775A2 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 12/06/2001 | WO2001091754A1 Protein kinase inhibitors |
| 12/06/2001 | WO2001091732A2 Medicament for combating respiratory depression |
| 12/06/2001 | WO2001091729A1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 12/06/2001 | WO2001070818A8 Anti-c2/c2a inhibitors of complement activation |
| 12/06/2001 | WO2001046392A3 Homologues of human heparanase and splice variants thereof |
| 12/06/2001 | WO2001045741A3 Methods for preparing pharmaceutical formulations |
| 12/06/2001 | WO2001038495A3 Method for producing a thrombocyte preparation and a thrombocyte preparation |
| 12/06/2001 | WO2001025257A3 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 12/06/2001 | WO2001016345A3 Sequence-specific dna recombination in eukaryotic cells |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2001010847A8 Novel integrin receptor antagonists |
| 12/06/2001 | WO2000077233A3 Complement-resistant non-mammalian dna viruses and uses thereof |
| 12/06/2001 | WO2000038517A9 Methods for reducing adverse side effects associated with cellular transplantation |
| 12/06/2001 | US20010049360 Betaglycan as an inhibin receptor and uses thereof |
| 12/06/2001 | US20010049106 ADAM (A Disintegrin And Metalloprotease) family of metalloproteases, and in addition contain thrombospondin domain (TS); treating diabetes, arthritis, cancer, solid tumors, autoimmune diseases |
| 12/06/2001 | US20010048921 Forming chimeric bone marrow |
| 12/06/2001 | DE10027025A1 Clycinamide Clycinamide |
| 12/06/2001 | DE10027024A1 Carbaminsäureester Carbamic |
| 12/06/2001 | DE10026699A1 Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage Formulation of heparin, glycosaminoglycan or Heparinoidbasis and use of the formulation and the formulation base |
| 12/06/2001 | DE10025464A1 Kombinierte Verwendung von Enzyminhibitoren zur Therapie von Autoimmunerkrankungen, bei Transplantationen und Tumorerkrankungen sowie Kombinationen von Enzyminhibitoren umfassende pharmazeutische Zubereitungen Combined use of enzyme inhibitors for the therapy of autoimmune diseases, transplantation and tumor diseases as well as combinations of enzyme inhibitors pharmaceutical preparations comprising |
| 12/06/2001 | CA2411323A1 Il-8 receptor antagonists |
| 12/06/2001 | CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | CA2410903A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | CA2410650A1 Medicament for combating respiratory depression |
| 12/06/2001 | CA2410453A1 Neuroprotective peptides |
| 12/06/2001 | CA2409597A1 Protein kinase inhibitors |
| 12/06/2001 | CA2409359A1 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 12/06/2001 | CA2409311A1 Regulators of apoptosis |
| 12/05/2001 | EP1160248A1 N-(Isoxazol-5-yl)-sulfonamide derivatives and their use as endothelin antagonists |
| 12/05/2001 | EP1159975A2 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159974A1 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159418A2 Muc-1 antagonists and methods of treating immune disorders |
| 12/05/2001 | EP1159417A2 Polynucleotides and proteins encoded thereby |
| 12/05/2001 | EP1159408A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 12/05/2001 | EP1159404A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 12/05/2001 | EP1159300A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 12/05/2001 | EP1159292A2 Compounds having growth hormone releasing activity |
| 12/05/2001 | EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta |
| 12/05/2001 | EP1159284A1 33 human secreted proteins |
| 12/05/2001 | EP1159264A2 INHIBITORS OF FACTOR Xa |
| 12/05/2001 | EP1158996A1 Novel amide derivatives as growth hormone secretagogues |
| 12/05/2001 | EP1084270A4 Inhibition of coagulation in blood and blood products |
| 12/05/2001 | EP0937036B1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 12/05/2001 | EP0912197B1 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 12/05/2001 | EP0828724B1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors |
| 12/05/2001 | EP0817639B1 Pharmaceutical composition containing selected lanthanum carbonate hydrates |
| 12/05/2001 | EP0669912B1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
| 12/05/2001 | CN1325447A Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
| 12/05/2001 | CN1325408A Compounds with growth hormone releasing propenties |
| 12/05/2001 | CN1325406A Crystalline forms of EtO2C-ch2-(r) Cgl-Aze-Pab-oh |
| 12/05/2001 | CN1325302A Use of dialkylfumarates |
| 12/05/2001 | CN1324647A Prepn. of hematopoietic tortoise-deer capsule |
| 12/05/2001 | CN1324631A Aplastic amenia treating hemopoietic medicine |
| 12/05/2001 | CN1075836C Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 12/05/2001 | CN1075725C Medicine for curing thrombocytopenic purpura and anemia |
| 12/04/2001 | US6326492 Heterocyclic protease inhibitors |
| 12/04/2001 | US6326403 Cardiovascular disorders |
| 12/04/2001 | US6326388 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level |
| 12/04/2001 | US6326378 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 12/04/2001 | US6326355 Method for the prevention and treatment of cachexia and anorexia |
| 12/04/2001 | US6326353 123therapy for septic shock; administering polymyxin by injection |
| 12/04/2001 | US6326205 Methods for use of Mpl ligands with primitive human stem cells |